Table 4 Toxicity by treatment cycle

From: Phase II trial of cisplatin and capecitabine in patients with squamous cell carcinoma of the head and neck, and correlative study of angiogenic factors

Cycle

1 (n=41)

2 (n=40)

3 (n=36)

4 (n=30)

5 (n=27)

6 (n=20)

Grade

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

Anaemia

6

1

0

0

11

1

1

0

7

2

1

0

12

3

0

0

7

6

1

0

9

2

1

0

Neutropenia

2

1

0

1

2

0

2

1

4

1

1

0

2

2

0

0

2

1

1

0

3

0

0

0

Thrombopenia

1

0

0

0

2

0

0

0

1

0

0

1

1

2

0

0

1

0

0

1

0

1

0

0

Asthenia

16

8

0

0

18

9

1

0

18

8

1

0

15

8

1

0

14

8

2

0

10

8

0

0

Anorexia

8

3

0

0

11

8

0

0

16

6

1

0

11

7

1

0

14

8

2

0

11

6

0

0

Hand–foot

0

0

0

0

0

1

0

0

8

2

0

0

16

3

1

0

8

10

1

0

6

11

0

0

Constipation

11

2

0

0

12

4

0

0

9

3

0

0

12

1

0

0

11

2

0

0

6

3

0

0

Nausea/vomiting

6

1

0

0

5

0

0

0

4

0

0

0

2

3

0

0

2

0

0

0

1

1

0

0

Alopecia

0

0

2

0

9

0

8

0

8

1

7

0

Mucositis

3

1

2

0

2

2

1

0

2

1

0

0

2

0

0

0

1

0

0

0

0

0

0

0

Neuropathy

0

0

0

0

0

0

0

0

1

0

0

0

2

0

0

0

0

1

0

0

2

1

0

0

Diarrhoea

0

0

1

0

0

0

0

0

1

0

0

0

1

0

0

0

0

0

0

0

0

0

0

0

Cardiotoxicity

0

0

0

0

0

0

1

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0